Committed to Curing Cancer
We behold the belief of a cancer-free life with advanced gene and immunotherapy technology.
CAR T-Cells Technology
US FDA has approved CAR T-cell therapy for B-cell acute lymphoblastic leukaemia, B-cell non-Hodgkin lymphoma and multiple myeloma.
CAR T-cells therapy are genetically modified T cells that possesses a wider and precise attack power to locate and eradicate cancer cells in the patient’s body.
Our Key Opinion Leader
“The emergence of CAR T-cell therapy is phenomenonal. It’s a breakthrough for cancer treatment after decades of research and clinical studies.”
Academician Emeritus Professor Dr. Cheong Soon Keng
Consultant Haematologist
